Clinical trial
Prospective, Multicenter, Non-interventional Post Market Release Study , to Examine Whether Pump Treatment Combined With the Use of Continuous Glucose Monitoring System is a Mean to Normalize Glycaemic Control.
NCT01369823 is registered in ClinicalTrials.gov with Medtronic Hellas Medical Devices ΑEE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter, Non-interventional Post Market Release Study , to Examine Whether Pump Treatment Combined With the Use of Continuous Glucose Monitoring System is a Mean to Normalize Glycaemic Control.
- Lead sponsor
- Medtronic Hellas Medical Devices ΑEE
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2009
- Completion date
- December 31, 2011
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes